NIH Record - National Institutes of Health

Investigational Covid-19 vaccine Well-Tolerated and Generates Immune Response in Older Adults

A phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published Sept. 29 in the New England Journal of Medicine describes the findings from the study, which was supported by NIAID.

Some Cerebral Palsy Cases May Be Tied to Brain-Wiring Genes

Researchers confirm that about 14 percent of all cases of cerebral palsy, a disabling brain disorder for which there are no cures, may be linked to a patient’s genes and suggest that many of those genes control how brain circuits become wired during early development.

The NIH Record

The NIH Record, founded in 1949, is the biweekly newsletter for employees of the National Institutes of Health.

Published 25 times each year, it comes out on payday Fridays.

Editor: Dana Talesnik
Dana.Talesnik@nih.gov

Associate Editor: Patrick Smith
Pat.Smith@nih.gov

Assistant Editor: Eric Bock
Eric.Bock@nih.gov

Staff Writer: Amber Snyder
Amber.Snyder@nih.gov